These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2325570)

  • 1. Studies of osteoporosis in Japan.
    Fujita T
    Metabolism; 1990 Apr; 39(4 Suppl 1):39-42. PubMed ID: 2325570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 8. Vitamin D metabolites and analogs in the treatment of osteoporosis.
    Jones G; Hogan DB; Yendt E; Hanley DA
    CMAJ; 1996 Oct; 155(7):955-61. PubMed ID: 8837546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis.
    Gillespie WJ; Henry DA; O'Connell DL; Robertson J
    Cochrane Database Syst Rev; 2000; (2):CD000227. PubMed ID: 10796331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The vitamin D metabolites in the pathogenesis and management of osteoporosis.
    Crilly RG; Horseman A; Peacock M; Nordin BE
    Curr Med Res Opin; 1981; 7(5):337-48. PubMed ID: 6894417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale for active vitamin D and analogs in the treatment of osteoporosis.
    Nishii Y
    J Cell Biochem; 2003 Feb; 88(2):381-6. PubMed ID: 12520540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis.
    Avenell A; Gillespie WJ; Gillespie LD; O'Connell DL
    Cochrane Database Syst Rev; 2005 Jul; (3):CD000227. PubMed ID: 16034849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of vitamin D, its metabolites, and analogs in the management of osteoporosis.
    Bikle DD
    Rheum Dis Clin North Am; 1994 Aug; 20(3):759-75. PubMed ID: 7984788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advantages of active vitamin D metabolites in the treatment of osteoporosis as compared with calciferol].
    Zofková I
    Vnitr Lek; 2001 Feb; 47(2):99-100. PubMed ID: 15635854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.
    Richy F; Schacht E; Bruyere O; Ethgen O; Gourlay M; Reginster JY
    Calcif Tissue Int; 2005 Mar; 76(3):176-86. PubMed ID: 15692726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immobilization osteoporosis and active vitamin D: effect of active vitamin D analogs on the development of immobilization osteoporosis in rats.
    Izawa Y; Makita T; Hino S; Hashimoto Y; Kushida K; Inoue T; Orimo H
    Calcif Tissue Int; 1981; 33(6):623-30. PubMed ID: 6799174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D deficiency and osteoporosis: the role of vitamin D deficiency and treatment with vitamin D and analogues in the prevention of osteoporosis-related fractures.
    Lips P
    Eur J Clin Invest; 1996 Jun; 26(6):436-42. PubMed ID: 8817154
    [No Abstract]   [Full Text] [Related]  

  • 14. Osteoporosis and vitamin D.
    Nordin BE; Morris HA
    J Cell Biochem; 1992 May; 49(1):19-25. PubMed ID: 1644849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
    Norman AW; Sergeev IN; Bishop JE; Okamura WH
    Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcidiol [25(OH)D3]: from diagnostic marker to therapeutical agent.
    Brandi ML; Minisola S
    Curr Med Res Opin; 2013 Nov; 29(11):1565-72. PubMed ID: 24020910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Administration of vitamin D3 and its active metabolites in the prevention and treatment of osteoporosis].
    Lips P
    Ned Tijdschr Geneeskd; 1996 Jan; 140(2):65-8. PubMed ID: 8569923
    [No Abstract]   [Full Text] [Related]  

  • 18. Osteoporosis and the metabolites of vitamin D.
    DeLuca HF
    Metabolism; 1990 Apr; 39(4 Suppl 1):3-9. PubMed ID: 2157943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D metabolites and bone mineralization in man.
    Bordier P; Rasmussen H; Marie P; Miravet L; Gueris J; Ryckwaert A
    J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical effect of bisphosphonate and vitamin D on osteoporosis: reappraisal of a multicenter double-blind clinical trial comparing etidronate and alfacalcidol.
    Fujita T; Orimo H; Inoue T; Kaneda K; Sakurai M; Morita R; Yamamoto K; Sugioka Y; Inoue A; Takaoka K; Yamamoto I; Hoshino Y; Kawaguchi H
    J Bone Miner Metab; 2007; 25(2):130-7. PubMed ID: 17323183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.